Brent R Lyda

Title: Brent R. Lyda: Innovator in Nuclear Hormone Receptor Modulation

Introduction

Brent R. Lyda is a notable inventor based in Jupiter, Florida. He has made significant contributions to the field of nuclear hormone receptor modulation. His work focuses on developing small molecule modulators that can effectively target specific receptors involved in various biological processes.

Latest Patents

Brent R. Lyda holds a patent for "Modulators of the nuclear hormone receptor ROR." This invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα, RORβ, or RORγ. The compounds described in the patent can act as effective modulators at concentrations that do not affect LXR receptors or other nuclear receptors. Additionally, the invention outlines methods for treating metabolic disorders, immune disorders, cancer, and CNS disorders where modulation of an ROR is medically indicated. He has 1 patent to his name.

Career Highlights

Brent R. Lyda is associated with The Scripps Research Institute, where he continues to advance research in his field. His work has implications for understanding and treating various health conditions through innovative approaches to receptor modulation.

Collaborations

Brent has collaborated with notable colleagues such as Theodore M. Kamenecka and Patrick Griffin. Their combined expertise contributes to the advancement of research in nuclear hormone receptors.

Conclusion

Brent R. Lyda's innovative work in the field of nuclear hormone receptor modulation showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various disorders significantly.